• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Steven Goetz Joins Motif Neurotech as Chief Technology Officer

    ZAP Surgical Wins Two More IP Battles with Elekta

    3D Systems Partners with Klarity to Expand Distribution of VSP Bolus Solution

    Zeus Introduces Absorv XSE Oriented Tubing

    Laminate's VasQ Nabs De Novo Nod to Create AVFs for Dialysis Access
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Back to School for Medical Device Cybersecurity Training

    Driving Clinical Trial Excellence to Help Study Teams Run a Faster Relay Race

    Medtech’s Supply Chain: From Disruption to Opportunity

    Are Medtech’s Mega-Deals Gone For Good?

    Will a Skilling Gap Hinder Organizational Readiness for Medtech’s New Age of AI?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    LEMO USA Inc.

    Medbio LLC

    Johari Digital Healthcare Ltd.

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Wearables Are Changing the Way We Collect Real-World Data in Clinical Trials

    Could Medtech Ever Stop a Hospital Killer in Their Tracks?

    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    LEMO USA Inc.

    Medbio LLC

    Johari Digital Healthcare Ltd.

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA OKs First Extragenital Tests for Chlamydia and Gonorrhea

    Hologic and Cepheid's tests spot these infections via the throat and rectum.

    FDA OKs First Extragenital Tests for Chlamydia and Gonorrhea
    PR Newswire05.24.19
    The U.S. Food and Drug Administration cleared for marketing two tests that can detect the presence of the bacteria Chlamydia trachomatis and Neisseria gonorrhoeae, which cause the sexually-transmitted infections, respectively, chlamydia and gonorrhea, through diagnostic testing of extragenital specimens. The Aptima Combo 2 Assay and the Xpert CT/NG are the first devices cleared for extragenital diagnostic testing of these infections via the throat and rectum. These tests were previously only cleared for testing urine, vaginal and endocervical samples.
     
    "Prior to now, there were no chlamydia or gonorrhea tests cleared for use on samples from the throat and rectum. The availability of these two tests will fill an unmet public health need, by allowing for more screening," said Tim Stenzel, M.D., Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health. "It is best for patients if both of these sexually transmitted infections are caught and treated right away, as significant complications can occur if left untreated. These clearances provide a mechanism for more easily diagnosing these infections."
     
    According to the Centers for Disease Control and Prevention's Sexually Transmitted Infections Surveillance Report, the rate of sexually transmitted infections is steadily increasing, with an estimated 1.7 million cases of chlamydia and more than 500,000 cases of gonorrhea in the U.S. in 2017 alone. Both infections can be contracted through vaginal, anal or oral intercourse. Typically, both infections can be easily treated, but if left untreated, both infections can cause serious complications for patients, including infertility.
     
    The Aptima Combo 2 Assay and Xpert CT/NG were reviewed through the premarket notification (510(k)) pathway. A 510(k) is a premarket submission made to the FDA to demonstrate that the device to be marketed is at least as safe and effective, that is, substantially equivalent, to a legally marketed device.
     
    In its evaluation of the devices, the FDA reviewed clinical data collected through a cross-sectional study coordinated by the Antibacterial Resistance Leadership Group, which is funded and supported by the National Institute of Allergy and Infectious Diseases. The study was a collaborative, multi-site clinical study of more than 2,500 patients that evaluated the diagnostic accuracy of multiple commercially available nucleic acid amplification tests for detection of Neisseria gonorrhoeae and Chlamydia trachomatis from throat and rectal sites. The results of this study, along with other information reviewed by the FDA, demonstrated that the Aptima Combo 2 Assay and the Xpert CT/NG for extragenital specimens are safe and effective for extragenital testing for chlamydia and gonorrhea.
     
    The FDA granted clearance of Aptima Combo 2 Assay to Hologic Inc.
     
    The FDA granted clearance of the Xpert CT/NG to Cepheid.
    Related Searches
    • detection
    • fda
    • hologic
    • diagnostic
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production
    Cepheid Cepheid's Combo COVID-19, Flu A/B, RSV Test Earns EUA
    Hologic Granted EUA for Asymptomatic COVID-19 Testing Hologic Granted EUA for Asymptomatic COVID-19 Testing
    Hologic Updates Brevera Breast Biopsy Platform Hologic Updates Brevera Breast Biopsy Platform
    Hologic Launches Validated COVID-19 Test Pooling Protocol Hologic Launches Validated COVID-19 Test Pooling Protocol
    RadNet, Hologic Collaborate on AI for Breast Health RadNet, Hologic Collaborate on AI for Breast Health
    Hologic	Hologic
    Hologic Launches SuperSonic MACH 40 Cart-Based Ultrasound Hologic Launches SuperSonic MACH 40 Cart-Based Ultrasound
    How Are MPO’s Top 30 Addressing COVID-19? How Are MPO’s Top 30 Addressing COVID-19?
    FDA Clears Roche to Expand Testing Menu on cobas 6800/8800 Systems for STDs FDA Clears Roche to Expand Testing Menu on cobas 6800/8800 Systems for STDs
    Beckman Coulter Beckman Coulter's Blood Test Analyzers Recalled Over Risk of Inaccurate Platelet Analyzing Results
    FDA Approves Device to Help Increase Access to More Lungs for Transplant FDA Approves Device to Help Increase Access to More Lungs for Transplant
    Hologic Launches Trident HD Specimen Radiography System Hologic Launches Trident HD Specimen Radiography System
    Massachusetts Medical Device Development Center Names $200K Challenge Winners Massachusetts Medical Device Development Center Names $200K Challenge Winners
    Hologic Hologic's Automated Cytology Slide and Molecular Sample System Gains CE Mark

    Related Breaking News

    • Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production

      Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production

      New plant aims to reach a run rate of 600 million QuickVue tests per year by the end of 2021.
      Michael Barbella, Managing Editor 02.18.21

    • Diagnostics
      Cepheid

      Cepheid's Combo COVID-19, Flu A/B, RSV Test Earns EUA

      Expected to begin shipping to U.S. customers this week.
      PR Newswire

    • Diagnostics
      Hologic Granted EUA for Asymptomatic COVID-19 Testing

      Hologic Granted EUA for Asymptomatic COVID-19 Testing

      Testing of pooled samples also authorized; new claims expected to help limit spread of COVID-19, open economy and schools.
      Business Wire 09.28.20


    • Chronic Disease | Diagnostics
      Hologic Updates Brevera Breast Biopsy Platform

      Hologic Updates Brevera Breast Biopsy Platform

      Now features new functionality, simplified storage, and improved waste management.
      Hologic Inc. 09.02.20

    • Diagnostics
      Hologic Launches Validated COVID-19 Test Pooling Protocol

      Hologic Launches Validated COVID-19 Test Pooling Protocol

      Helps labs deliver greater quantities of highly accurate test results, reduce turnaround times.
      Business Wire 08.11.20

    Loading, Please Wait..

    Trending
    • Cardiosense Begins SEISMIC-HF I Heart Failure Trial
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • Exo Introduces The Exo Iris To Market
    • A New Approach To Post-Market Surveillance
    • Varian Buys Aspekt Solutions To Bolster Advanced Oncology Biz
    Breaking News
    • MCRA Expands Biocompatibility Division With Board-Certified Toxicologist Hire
    • ISO 13485 Certification Awarded to Inspira Technologies
    • ZOLL Expands Temperature Management Portfolio to Include IQool System
    • Steven Goetz Joins Motif Neurotech as Chief Technology Officer
    • ZAP Surgical Wins Two More IP Battles with Elekta
    View Breaking News >
    CURRENT ISSUE

    October 2023

    • MPO's 2023 Medtech Supply Chain Survey
    • Exceeding Medical Device Extrusion Expectations
    • Medical Device Micromolders Discuss the 'Minor Details'
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    Hugh Grant to Retire from PPG Board of Directors
    BASF Recognizes Hard Work with Five Prestigious Awards at SEMA
    Arkema Will Decarbonize Acrylics Production at its Carling, France Site
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Steven Goetz Joins Motif Neurotech as Chief Technology Officer
    ZAP Surgical Wins Two More IP Battles with Elekta
    3D Systems Partners with Klarity to Expand Distribution of VSP Bolus Solution
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
    Peptone Expands Leadership Team with Key Executive Hires
    Evonik Boosts Portfolio of Nanoparticle Technologies
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Maybelline New York Launches Virtual Campaign in Roblox
    Taramar Unveils Skincare Solution Powered by Kelp
    NYX Professional Makeup Partners with the New York Liberty
    Happi

    Latest Breaking News From Happi

    Black Girl Ventures Foundation, Rare Beauty Brands and JCPenney Reveal 2023 National Competition Finalists
    Catch Partners with Rare Beauty, Introduces First Mobile App
    Haircolor Company oVertone and Franzia Wines Create Limited Edition Hair Conditioners
    Ink World

    Latest Breaking News From Ink World

    Arkema Will Decarbonize Acrylics Production at Carling, France Site
    Micro Powders Showcases New Natural, PTFE Alternative Additives at 2023 WCS
    Roland DG Direct-To-Film Printer Ink, Powder Receive ECO PASSPORT Certification
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    APR publishes expanded Global Design Catalog
    Anjou adds Bobst Digital Master 340
    Label Summit Latin America returns to Colombia
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ed Thomas Receives INDA Lifetime Technical Service Award
    ExxonMobil Works with JL Goor to Help Drive Growth in Ireland and U.K. Healthcare Sector
    Lee C. Stewart Resigns from Glatfelter Board
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Clears 4WEB Medical's New Integrated Cervical Plate
    CTL Amedica Granted ECAT Approval from Defense Logistics Agency
    Intech Acquires Lenkbar LLC
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Emerson Ventures Invests in First Resonance
    Nearly Six in 10 Warehouse Leaders Plan to Deploy RFID by 2028: Zebra
    Wiliot to Show Enhanced Version of Wiliot Cloud, IoT Pixels, at MWC Las Vegas 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login